Autoimmune Adrenocortical Failure Completed Phase 4 Trials for Rituximab (DB00073)

IndicationStatusPhase
DBCOND0041798 (Autoimmune Adrenocortical Failure)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00753597Rescue of Steroidogenic Capacity in Adrenocortical Failure Study (RADS)Prevention